红日药业：公司控制权稳定，生产经营正常

Core Viewpoint - Hongri Pharmaceutical (300026) confirmed on November 13 that the company's control is stable and its production and operations are normal [1] Group 1 - The company reassured investors about the stability of its control [1] - The company stated that its production and operations are functioning normally [1]